Barbara A. Conley

12.3k citations

143 papers · 6.0k indexed · 1 hit paper · h-index 39

Impact in

Oncology top 1%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Screening and Detection
Cancer Research top 1%
- Cancer Genomics and Diagnostics

Papers in

Cancer Research 43
- Cancer Genomics and Diagnostics 34
Otorhinolaryngology 12
- Head and Neck Cancer Studies 12

Co-authors: Calvin Vary Daniel J. Sargent Stanley R. Hamilton Lisa M. McShane Laurence Collette Carmen J. Allegra Carmelo Bernabéu Merrill J. Egorin
Journals: Journal of Clinical Oncology (34 papers)Cancer Chemotherapy and Pharmacology (9 papers)Clinical Cancer Research (8 papers)Cancer Research (6 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)
Partner nations: United States Malaysia Canada

In The Last Decade

Barbara A. Conley

135 papers receiving 5.9k citations

Hit Papers

align trajectories log scale

Prognostic Factors in Colorectal Cancer 2000 · 993 citations

Peers

Countries citing papers authored by Barbara A. Conley

Since Specialization

Citations

This map shows the geographic impact of Barbara A. Conley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Conley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Conley more than expected).

Fields of papers citing papers by Barbara A. Conley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Conley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Conley. The network helps show where Barbara A. Conley may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara A. Conley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara A. Conley Line = papers co-authored together Barbara A. Conley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1K Clinical Cancer Research ·Carolyn K. McCourt, Zihan Wei, Kevin Kalinsky, Robert J. Gray, Victoria Wang, Lisa M. McShane, Larry Rubinstein, David R. Patton, P. Mickey Williams, Stanley R. Hamilton, Jeremy Force, Tieqiao, James V. Tricoli, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O’Dwyer, Alice P. Chen, Keith T. Flaherty	2025	2
2	Dabrafenib and trametinib in patients with tumors with BRAF V600E/k mutations: Updated results from NCI-MATCH arm H. Journal of Clinical Oncology ·April K.S. Salama, Victoria Wang, Erin Macrae, Jong‐In Park, Helen X. Chen, Robert J. Gray, Lisa M. McShane, Larry Rubinstein, Onny Heru Setyaditama, Stanley R. Hamilton, Deborah K. Armstrong, James V. Tricoli, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O’Dwyer, Alice P. Chen, Keith T. Flaherty	2024	1
3	Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A JCO Precision Oncology ·Scott Gettinger, William R. Borland, Karen L. Reckamp, Jeffrey A. Moscow, Robert J. Gray, Victoria Wang, Lisa M. McShane, Larry Rubinstein, David R. Patton, P. Mickey Williams, Stanley R. Hamilton, Xiao–Tang Kong, James V. Tricoli, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O’Dwyer, Doctor Mukhawana, Keith T. Flaherty	2024	2
4	Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C Clinical Cancer Research ·Mark H. O’Hara, Opeyemi A. Jegede, Mark A. Dickson, Angela DeMichele, Richard Piekarz, Robert J. Gray, Victoria Wang, Lisa M. McShane, Larry Rubinstein, David R. Patton, P. Mickey Williams, Stanley R. Hamilton, Adedayo A. Onitilo, James V. Tricoli, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O’Dwyer, Alice P. Chen, Keith T. Flaherty	2024	1
5	Tumor Genomic Profiling Practices and Perceptions: A Survey of Physicians Participating in the NCI-MATCH Trial JCO Precision Oncology ·Alice P. Chen, Keith T. Flaherty, Peter J. O’Dwyer, Bruce J. Giantonio, Donna M. Marinucci, Ju‐Whei Lee, K. Riaz, Mary Lou Smith, Carol White, Barbara A. Conley	2020	8
6	Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131) Clinical Cancer Research ·Douglas B. Johnson, Fengmin Zhao, Marcus Smith Noel, Gregory J. Riely, Edith P. Mitchell, James R. Wright, Helen X. Chen, Robert J. Gray, Shuli Li, Lisa M. McShane, Larry Rubinstein, David R. Patton, R. B. Escue, J Ferre, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O’Dwyer, Alice P. Chen, Keith T. Flaherty	2020	42
7	A transatlantic perspective on the integration of immuno-oncology prognostic and predictive biomarkers in innovative clinical trial design Seminars in Cancer Biology ·Marie Morfouace, Stephen M. Hewitt, Roberto Salgado, Dini Isnindarwati, Saskia Litière, Sabine Tejpar, V. Golfinopoulos, Tracy Lively, Magdalena Thurin, Barbara A. Conley, Denis Lacombe	2018	2
8	Application of Molecular Profiling in Clinical Trials for Advanced Metastatic Cancers JNCI Journal of the National Cancer Institute ·Shivaani Kummar, 浩敏柳, Chih-Jian Lih, Eric C. Polley, Y.M. Klenov, Larry Rubinstein, Yongmei Zhao, Richard Simon, Barbara A. Conley, James H. Doroshow	2015	41
9	Endoglin is required in Pax3-derived cells for embryonic blood vessel formation Developmental Biology ·Kira Young, Luke T. Krebs, Muhamadovna Mavlyuda Qosimova, Barbara A. Conley, Talita Mourão Chaves Corriça Loyola, Helen M. Arthur, Lucy Liaw, Thomas Gridley, Calvin Vary	2015	7
10	National Cancer Institute's Precision Medicine Initiatives for the New National Clinical Trials Network American Society of Clinical Oncology Educational Book ·Jeffrey S. Abrams, Barbara A. Conley, Margaret Mooney, James A. Zwiebel, Alice P. Chen, John J. Welch, Naoko Takebe, Shakun Malik, Lisa M. McShane, Edward L. Korn, Mickey Williams, Louis M. Staudt, James H. Doroshow	2014	122
11	Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers JNCI Journal of the National Cancer Institute ·哲男妹尾, Boris Freidlin, Edward L. Korn, Barbara A. Conley, Jeffrey S. Abrams, Lisa M. McShane	2013	101
12	Criteria for the use of omics-based predictors in clinical trials Nature ·Lisa M. McShane, Margaret M. Cavenagh, Tracy Lively, David A. Eberhard, William L. Bigbee, P. Mickey Williams, Jill P. Mesirov, Mei‐Yin C. Polley, Kelly Y. Kim, James V. Tricoli, Jeremy M. G. Taylor, Deborah J. Shuman, Richard Simon, James H. Doroshow, Barbara A. Conley	2013	164
13	Multicenter Trial of EC145 in Advanced, Folate-Receptor Positive Adenocarcinoma of the Lung Journal of Thoracic Oncology ·Martin J. Edelman, Wael A. Harb, 朱郁华, Ralph V. Boccia, Michael Kraut, Philip Bonomi, Barbara A. Conley, John Rogers, Richard A. Messmann, Edward B. Garon	2012	33
14	Endoglin Regulates Cancer–Stromal Cell Interactions in Prostate Tumors Cancer Research ·Diana Romero, Christine J. O’Neill, Aleksandra Terzic, Liangru Contois, Kira Young, Barbara A. Conley, Raymond C. Bergan, Peter C. Brooks, Calvin Vary	2011	48
15	Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration Carcinogenesis ·Diana Romero, Aleksandra Terzic, Barbara A. Conley, Clarissa S. Craft, Borko Jovanovic, Raymond C. Bergan, Calvin Vary	2009	32
16	Novel biochemical pathways of endoglin in vascular cell physiology Journal of Cellular Biochemistry ·Carmelo Bernabéu, Barbara A. Conley, Calvin Vary	2007	111
17	Inhibition of nuclear factor-κB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma International Journal of Radiation OncologyBiologyPhysics ·Carter Van Waes, Angela A. Chang, Peter F. Lebowitz, Colleen Druzgal, Zhong Chen, Yusri Elsayed, John B. Sunwoo, Susan F. Rudy, John C. Morris, James B. Mitchell, Kevin Camphausen, David Gius, Julian Adams, Edward A. Sausville, Barbara A. Conley	2005	93
18	Workshop report: Organ preservation strategies in advanced head and neck cancer—Current status and future directions Head & Neck ·Gregory T. Wolf, Arlene A. Forastiere, Kian Ang, Bruce Brockstein, Barbara A. Conley, Helmuth Goepfert, Dennis H. Kraus, Jean‐Louis Lefebvre, Thomas F. Pajak, David G. Pfister, Sinta Ardhillatul Jannah	1999	29
19	N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma Carcinogenesis ·Md Sayed Ali Sheikh, Zhi‐Ming Shao, Fabio Belloni, José V. Ordóñez, Barbara A. Conley, Suhlan Wu, Marcia I. Dawson, Qi-Xia Han, Wan-Ru Chao, 康彦林葉, Richard M. Niles, Joseph A. Fontana	1995	115
20	Involvement of monoamine oxidase and diamine oxidase in the metabolism of the cell differentiating agent hexamethylene bisacetamide (HMBA) Life Sciences ·Barbara A. Conley, Patrick S. Callery, Merrill J. Egorin, Babu Subramanyam, Ozoda Aziz qizi Xolmurodova, Su‐Shu Pan	1988	4

About Barbara A. Conley

Barbara A. Conley is a scholar working on Cancer Research, Otorhinolaryngology, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 143 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (34 papers), Lung Cancer Treatments and Mutations (22 papers), Colorectal Cancer Treatments and Studies (20 papers), Head and Neck Cancer Studies (12 papers), Genetic factors in colorectal cancer (11 papers), Cancer Treatment and Pharmacology (11 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Statistical Methods in Clinical Trials (9 papers). The work is most often cited by research in Oncology (2.7k citations), Cancer Research (1.3k citations), Otorhinolaryngology (327 citations), Pulmonary and Respiratory Medicine (1.5k citations) and Pathology and Forensic Medicine (742 citations). Barbara A. Conley has collaborated with scholars based in United States, Malaysia and Canada. Frequent co-authors include Calvin Vary, Daniel J. Sargent, Stanley R. Hamilton, Lisa M. McShane, Laurence Collette, Carmen J. Allegra, Carmelo Bernabéu, Merrill J. Egorin, James V. Tricoli and Harry S. Cooper. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Clinical Cancer Research, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact